Loviselle Singapore: PLLA Collagen Biostimulator

Loviselle PLLA Collagen Biostimulator in Singapore - SOL Aesthetics

Loviselle is generating interest among those researching collagen biostimulators in Singapore because it works differently from a traditional dermal filler. Instead of adding external volume that remains in the tissue, it uses poly-L-lactic acid microspheres to stimulate the body’s own collagen production over time.

This makes it relevant for those looking at facial deflation, reduced skin firmness, and changes in tissue quality that cannot always be addressed by volume replacement alone. The treatment is gradual by design, with visible changes developing over weeks and continuing over months.

For those comparing non-surgical facial rejuvenation options, Loviselle is best understood as a collagen biostimulator, not a quick volumising filler. Suitability depends on facial anatomy, skin condition, medical history, and a doctor’s assessment.

What Is Loviselle?

Loviselle is a poly-L-lactic acid collagen biostimulator. It is supplied as a lyophilised powder, which means it is freeze-dried and reconstituted before injection. The powder is typically mixed with sterile saline and lidocaine before treatment.

The active ingredient is PLLA microspheres. The formulation also contains carboxymethylcellulose sodium and mannitol, which help create the injectable suspension when the product is prepared.

Unlike a traditional dermal filler, Loviselle does not rely on a gel that stays in place to provide lasting volume. Its main purpose is to stimulate collagen production gradually. The injected PLLA microspheres act as a scaffold within the tissue, encouraging a biological response that helps rebuild collagen structure over time.

This distinction is important. Loviselle is not designed for instant contouring in the way a standard hyaluronic acid filler is. It is considered when the treatment goal is gradual improvement in skin structure, firmness, and diffuse facial support.

How Loviselle Works

The Temporary Carrier Phase

After injection, the saline and carrier fluid provide temporary tissue support. This can create a short-lived visible effect in the treated area, but it is not the final result of the treatment.

The carrier fluid is absorbed by the body within about 3 to 5 days. As this fluid dissipates, the early visible fullness reduces. This is expected and should not be mistaken for treatment failure, as the collagen-stimulating phase has not yet fully developed.

The Collagen Stimulation Phase

The PLLA microspheres remain in the tissue after the carrier fluid is absorbed. As the PLLA gradually breaks down, it releases L-lactic acid, which acts as a biological signalling molecule.

This signalling helps stimulate fibroblast activity. Fibroblasts are the cells responsible for producing new collagen within the skin and supporting tissue.

Over the following weeks and months, the body’s collagen response gradually develops. Visible changes may begin from around 4 to 6 weeks, with progressive improvement over time depending on individual collagen response, treatment plan, and skin condition.

Type I and Type III Collagen: Why It Matters

Loviselle stimulates both Type I and Type III collagen. Type I collagen provides structural density and firmness, helping the tissue feel more supported. Type III collagen is associated with elasticity and suppleness, which contributes to a softer and more natural skin quality.

This matters because collagen stimulation should not create a rigid or overfilled look. The goal is to support the skin’s underlying structure while allowing the face to retain natural movement and softness.

In practical terms, this means the treatment is not simply about filling a hollow. It is about encouraging the skin and tissue to regain some of the support and resilience that can reduce with age.

Treatment Areas

Loviselle is typically used in areas where diffuse volume loss, reduced support, or collagen depletion affects facial structure. Common treatment areas include:

  • Mid-face and cheekbones, also known as the malar region
  • Nasolabial folds, also known as smile lines
  • Temporal hollowing
  • Jawline and lower face
  • Pan-facial deflation, where volume loss is more generalised across the face

Certain areas are not suitable for Loviselle. These include the lips, tear troughs, periorbital hollows, and perioral lines. These areas are more delicate and require different product characteristics because of their anatomy and movement.

A consultation with a doctor is needed to assess whether Loviselle is appropriate for your facial structure, skin condition, and treatment goals.

What to Expect from a Loviselle Course

Loviselle is usually performed as a course of treatments rather than a single session. A typical course involves 3 to 4 sessions, spaced about 3 to 6 weeks apart.

This staged approach is important because collagen stimulation develops gradually. It allows the doctor to review how your tissue responds before deciding whether more products should be added.

This matters because Loviselle cannot be dissolved or reversed like a hyaluronic acid filler. Careful planning helps reduce the risk of overcorrection and supports a more measured treatment approach.

After each session, there may be temporary swelling, redness, bruising, tenderness, or firmness at the injection sites. The early fullness from the carrier fluid usually settles within days, while the collagen response develops over weeks to months.

Realistic expectations are important. Loviselle is not designed for instant, dramatic contouring. It is considered for those who understand that visible change is gradual and requires a planned course.

How Long Do Results Last?

Results from Loviselle may last beyond 30 months after a full course, although individual results vary. Factors such as age, collagen response, skin condition, lifestyle, treatment area, and the number of sessions can influence longevity.

The PLLA microspheres are fully metabolised by the body within about 18 to 24 months. However, the collagen produced during the stimulation phase remains after the PLLA itself has broken down.

Maintenance sessions every 18 to 24 months may be discussed, depending on your response and treatment goals. A doctor will usually review tissue quality and facial support before recommending any maintenance plan.

Who May Be Suited to This Treatment?

Loviselle may be suited to those experiencing diffuse facial volume loss, reduced skin elasticity, or skin that feels less structurally supported over time. It is especially relevant when the concern is not one specific hollow, but a broader change in facial firmness and tissue quality.

It may also be considered by those who have tried standard hyaluronic acid fillers and feel that replacing volume alone does not fully address their concerns. Loviselle works differently because it focuses on collagen stimulation rather than adding a gel-based volume effect that remains in place.

This treatment is better suited to those who understand that changes develop gradually. Visible improvement takes weeks rather than days, and a full treatment plan usually involves a course of sessions.

It may appeal to those who are comfortable with a non-reversible treatment and prefer a natural, soft-looking outcome over dramatic contouring. A consultation with a doctor is needed to assess suitability, facial anatomy, and medical history.

Loviselle vs. Standard Hyaluronic Acid Filler

Standard hyaluronic acid fillers are widely used for precise volume restoration, contouring, and shape refinement. They are often chosen when the treatment goal is to add structure in a targeted area, such as the cheeks, chin, or jawline.

Loviselle works differently. It does not add external volume that persists in the tissue. Instead, it stimulates the body to rebuild collagen structure gradually over months.

Another important difference is reversibility. Hyaluronic acid fillers can be dissolved in certain situations, while Loviselle cannot be dissolved once injected. This is why careful assessment, appropriate placement, and staged treatment planning are important.

Loviselle vs. Older Generation PLLA Biostimulators

PLLA has been used in aesthetic medicine for many years. Older generation PLLA biostimulators used irregular and variably sized particles, which were associated with a higher risk of nodule formation and often required post-treatment massage.

Loviselle uses smooth, spherical microspheres that measure about 20 to 50 microns in diameter. This particle range is important because particles smaller than 20 microns can be cleared too quickly by the immune system, while particles larger than 50 microns carry a higher risk of granulomatous reactions.

The smoother and more uniform microsphere structure is designed to integrate more evenly into tissue. This helps reduce inflammatory risk when the treatment is properly reconstituted, placed at the correct depth, and administered by a qualified doctor.

Possible Side Effects and Safety Considerations

As with all injectable treatments, side effects may occur. Common transient effects include redness, swelling, bruising, tenderness, and temporary firmness at the injection sites. These usually settle as the treated area recovers.

Less common effects include unevenness or delayed nodule formation. Rare but serious complications, such as vascular occlusion, can occur with injectable treatments and require prompt medical attention.

Loviselle should be administered by a qualified doctor who understands facial anatomy, correct product reconstitution, injection depth, and staged treatment planning. Proper technique and suitable case selection help reduce risks.

This treatment is not suitable for everyone. It should not be used in those with known allergy to PLLA, carboxymethylcellulose sodium, or mannitol, active skin infections, certain inflammatory conditions at the injection site, autoimmune disorders affecting healing, a history of keloid or hypertrophic scarring, pregnancy, breastfeeding, or those under 18 years of age.

Pre and Post-Treatment Care

Before Your Treatment

  • Avoid blood-thinning medications such as NSAIDs, unless prescribed by your doctor
  • Avoid vitamin E supplements before treatment if advised by the clinic
  • Avoid alcohol close to the treatment date, as it can increase the risk of bruising
  • Inform the doctor about any medications, supplements, allergies, or previous injectable treatments
  • Do not proceed with treatment if there is an active skin infection, rash, or inflammation near the intended injection area
  • Discuss any history of keloid scarring, hypertrophic scarring, autoimmune conditions, or healing issues before treatment

After Your Treatment

  • Avoid saunas and heat exposure for 48 to 72 hours
  • Avoid intense exercise for 48 to 72 hours
  • Avoid facial massage unless advised by the doctor
  • Avoid pressure on the treated areas during the early recovery period
  • Use sun protection while the skin is recovering
  • Attend review appointments so the doctor can assess your collagen response and treatment progress

Frequently Asked Questions

The early fullness from the carrier fluid usually reduces within a few days. The collagen-stimulating effect develops gradually, with visible changes often starting from around 4 to 6 weeks and continuing over the following months.

A typical Loviselle course involves 3 to 4 sessions, spaced around 3 to 6 weeks apart. The exact number depends on facial anatomy, skin condition, collagen response, and the doctor’s treatment plan.

No. Loviselle cannot be dissolved because it is not a hyaluronic acid filler. This is why consultation, staged treatment planning, and conservative placement are important before proceeding.

A standard hyaluronic acid filler adds volume through a gel that occupies space within the tissue. Loviselle works by stimulating collagen production over time, so the visible changes develop gradually rather than through lasting external volume.

Results may last beyond 30 months after a full course, although individual response varies. The PLLA microspheres are metabolised within about 18 to 24 months, while the collagen produced during treatment remains beyond the breakdown of the PLLA itself.

Loviselle is not suitable for those with known allergy to PLLA, carboxymethylcellulose sodium, or mannitol. It is also not suitable for those with active skin infections at the injection site, severe inflammatory skin conditions, autoimmune disorders affecting healing, a history of keloid or hypertrophic scarring, pregnancy, breastfeeding, or those under 18 years of age.

Loviselle may be combined with other aesthetic treatments in a doctor-led treatment plan. The timing, order, and suitability of combination treatments depend on your facial anatomy, skin condition, previous treatments, and treatment goals.

Consult a Doctor at SOL Aesthetics

At SOL Aesthetics, we offer personalised non-surgical aesthetic treatments for face and body concerns, including Loviselle. Our clinic is located at The Cathay, Dhoby Ghaut.

As Medical Director of SOL Aesthetics, Dr Sii Sik Liong assesses each case with attention to facial anatomy, treatment suitability, and safety. As a faculty member of Allergan Medical Institute, together with his appointment as a trainer for filler injection and wrinkle injection in Singapore and the APAC region, he is accredited in a range of aesthetic procedures.

If you are considering Loviselle, we invite you to come in for a consultation and have a proper discussion about your concerns, skin condition, and treatment goals. From there, we can advise whether this treatment is appropriate for you, or whether another approach may be more suitable.

Book An Appointment